Boehringer Ingelheim
| Boehringer Ingelheim's headquarters in Ingelheim, Germany | |
| Company type | Private | 
|---|---|
| Industry | Pharmaceuticals | 
| Founded | 1885 in Ingelheim am Rhein, Germany | 
| Founder | Albert Boehringer | 
| Headquarters | , Germany | 
| Area served | Worldwide | 
| Key people | 
 | 
| Products | Pharmaceuticals and Animal Health | 
| Revenue | €26.8 billion (2024) | 
| Owner | Boehringer, Liebrecht and von Baumbach families | 
| Number of employees | 54,500 (2024) | 
| Website | boehringer-ingelheim | 
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one.
Headquartered in Ingelheim, it operates globally with more than 54,000 employees in 78 countries. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families. The company's key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). The corporate logo of Boehringer Ingelheim depicts a stylized rendition of the central section of the imperial palace of Charlemagne.